Dr. Chad Zender, MD
Claim this profileStudies Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
1 reported clinical trial
3 drugs studied
More about Chad Zender, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Chad Zender, MD has experience with
- Cesium-131
- Pembrolizumab
- Salvage Surgery
Breakdown of trials Chad Zender, MD has run
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chad Zender, MD specialize in?
Chad Zender, MD focuses on Squamous Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. In particular, much of their work with Squamous Cell Carcinoma has involved treating patients, or patients who are undergoing treatment.
Is Chad Zender, MD currently recruiting for clinical trials?
No, Chad Zender, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Chad Zender, MD has studied deeply?
Yes, Chad Zender, MD has studied treatments such as Cesium-131, Pembrolizumab, Salvage Surgery.
What is the best way to schedule an appointment with Chad Zender, MD?
Apply for one of the trials that Chad Zender, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.